A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137
Marine microorganisms live in dramatically different environments and have attracted much attention for their structurally unique natural products with potential strong biological activity. Based on the one strain-many compounds (OSMAC) strategy and liquid chromatography mass spectrometry (LC-MS) me...
Gespeichert in:
Veröffentlicht in: | Applied microbiology and biotechnology 2020-02, Vol.104 (4), p.1533-1543 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1543 |
---|---|
container_issue | 4 |
container_start_page | 1533 |
container_title | Applied microbiology and biotechnology |
container_volume | 104 |
creator | Zhang, Jingyu Li, Bixiao Qin, Yujie Karthik, Loganathan Zhu, Guoliang Hou, Chengjian Jiang, Lan Liu, Miaomiao Ye, Xin Liu, Mei Hsiang, Tom Dai, Huanqin Zhang, Lixin Liu, Xueting |
description | Marine microorganisms live in dramatically different environments and have attracted much attention for their structurally unique natural products with potential strong biological activity. Based on the one strain-many compounds (OSMAC) strategy and liquid chromatography mass spectrometry (LC-MS) methods, our continuing efforts on the investigation of novel active compounds from marine
Verrucosispora
sp. MS100137 has led to the identification of a new polycyclic metabolite, abyssomicin Y (
1
), together with six known abyssomicin and proximicin analogs (
2
–
7
). Abyssomicin Y is a type I abyssomicin with an epoxide group at C-8 and C-9. Compounds
1
–
3
showed potent inhibitory effects against the influenza A virus; their observed inhibition rates were 97.9%, 98.3%, and 95.9%, respectively, at a concentration of 10 μM, and they displayed lower cytotoxicity than
4
. The structures were determined by different NMR techniques and HRMS experiments. This investigation revealed that OSMAC could serve as a useful method for enabling the activation of the silent genes in the microorganism and for the formation of previously unreported active secondary metabolites. |
doi_str_mv | 10.1007/s00253-019-10217-2 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2332082175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A612511143</galeid><sourcerecordid>A612511143</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-9c2f16fb6d7d6ddd8fd21ecfcf0975369b71eeaf8432f043c5e1e8ebe8bccd3a3</originalsourceid><addsrcrecordid>eNp9kl9rFDEUxYModl39Aj5IwBd9yJo_M5mZx6VULVQEq76GTHKzps4kazKzdf30pm6trIjkIZD8zuWew0HoKaMrRmnzKlPKa0Eo6wijnDWE30MLVglOqGTVfbSgrKlJU3ftCXqU8xWljLdSPkQngrVdJWS1QHmNA1xj3e9zjqM3PuBtHPZfYfIW8LWfvmAdJk98cMMM4YfGa7zzac5Ym8nv_LTHLsURazzq5AMQC8nvwOLPkNJsYvZ5G5PGebvC7y7L2kw0j9EDp4cMT27vJfr0-uzj6Vty8f7N-en6gpiaiYl0hjsmXS9tY6W1tnWWMzDOONo1tZBd3zAA7dri2NFKmBoYtNBD2xtjhRZL9OIwd5vitxnypEafDQyDDhDnrLgQnLYluLqgz_9Cr-KcQtmuUJXkspaFvqM2egBVIolT0uZmqFpLxmvGSvqFWv2DKsdCCTgGcL68HwleHgkKM8H3aaPnnNX55Ydjlh9Yk2LOCZzaJl-i3ytG1U0r1KEVqrRC_WpFMbBEz27dzf0I9k7yuwYFEAcgl6-wgfTH_n_G_gQ_CcCE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2346265623</pqid></control><display><type>article</type><title>A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137</title><source>SpringerLink Journals - AutoHoldings</source><creator>Zhang, Jingyu ; Li, Bixiao ; Qin, Yujie ; Karthik, Loganathan ; Zhu, Guoliang ; Hou, Chengjian ; Jiang, Lan ; Liu, Miaomiao ; Ye, Xin ; Liu, Mei ; Hsiang, Tom ; Dai, Huanqin ; Zhang, Lixin ; Liu, Xueting</creator><creatorcontrib>Zhang, Jingyu ; Li, Bixiao ; Qin, Yujie ; Karthik, Loganathan ; Zhu, Guoliang ; Hou, Chengjian ; Jiang, Lan ; Liu, Miaomiao ; Ye, Xin ; Liu, Mei ; Hsiang, Tom ; Dai, Huanqin ; Zhang, Lixin ; Liu, Xueting</creatorcontrib><description>Marine microorganisms live in dramatically different environments and have attracted much attention for their structurally unique natural products with potential strong biological activity. Based on the one strain-many compounds (OSMAC) strategy and liquid chromatography mass spectrometry (LC-MS) methods, our continuing efforts on the investigation of novel active compounds from marine
Verrucosispora
sp. MS100137 has led to the identification of a new polycyclic metabolite, abyssomicin Y (
1
), together with six known abyssomicin and proximicin analogs (
2
–
7
). Abyssomicin Y is a type I abyssomicin with an epoxide group at C-8 and C-9. Compounds
1
–
3
showed potent inhibitory effects against the influenza A virus; their observed inhibition rates were 97.9%, 98.3%, and 95.9%, respectively, at a concentration of 10 μM, and they displayed lower cytotoxicity than
4
. The structures were determined by different NMR techniques and HRMS experiments. This investigation revealed that OSMAC could serve as a useful method for enabling the activation of the silent genes in the microorganism and for the formation of previously unreported active secondary metabolites.</description><identifier>ISSN: 0175-7598</identifier><identifier>EISSN: 1432-0614</identifier><identifier>DOI: 10.1007/s00253-019-10217-2</identifier><identifier>PMID: 31894364</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Actinomycetes ; Antiviral agents ; Biological activity ; Biomedical and Life Sciences ; Biotechnological Products and Process Engineering ; Biotechnology ; Control ; Cytotoxicity ; Health aspects ; Influenza ; Influenza A ; Influenza viruses ; Life Sciences ; Liquid chromatography ; Marine bacteria ; Marine microorganisms ; Mass spectrometry ; Mass spectroscopy ; Metabolites ; Microbial Genetics and Genomics ; Microbiology ; Microorganisms ; Natural products ; NMR ; Nuclear magnetic resonance ; Physiological aspects ; Polyketides ; Secondary metabolites ; Testing ; Toxicity ; Transcription activation ; Viruses</subject><ispartof>Applied microbiology and biotechnology, 2020-02, Vol.104 (4), p.1533-1543</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>COPYRIGHT 2020 Springer</rights><rights>Applied Microbiology and Biotechnology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-9c2f16fb6d7d6ddd8fd21ecfcf0975369b71eeaf8432f043c5e1e8ebe8bccd3a3</citedby><cites>FETCH-LOGICAL-c513t-9c2f16fb6d7d6ddd8fd21ecfcf0975369b71eeaf8432f043c5e1e8ebe8bccd3a3</cites><orcidid>0000-0001-6581-6818</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00253-019-10217-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00253-019-10217-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31894364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Jingyu</creatorcontrib><creatorcontrib>Li, Bixiao</creatorcontrib><creatorcontrib>Qin, Yujie</creatorcontrib><creatorcontrib>Karthik, Loganathan</creatorcontrib><creatorcontrib>Zhu, Guoliang</creatorcontrib><creatorcontrib>Hou, Chengjian</creatorcontrib><creatorcontrib>Jiang, Lan</creatorcontrib><creatorcontrib>Liu, Miaomiao</creatorcontrib><creatorcontrib>Ye, Xin</creatorcontrib><creatorcontrib>Liu, Mei</creatorcontrib><creatorcontrib>Hsiang, Tom</creatorcontrib><creatorcontrib>Dai, Huanqin</creatorcontrib><creatorcontrib>Zhang, Lixin</creatorcontrib><creatorcontrib>Liu, Xueting</creatorcontrib><title>A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137</title><title>Applied microbiology and biotechnology</title><addtitle>Appl Microbiol Biotechnol</addtitle><addtitle>Appl Microbiol Biotechnol</addtitle><description>Marine microorganisms live in dramatically different environments and have attracted much attention for their structurally unique natural products with potential strong biological activity. Based on the one strain-many compounds (OSMAC) strategy and liquid chromatography mass spectrometry (LC-MS) methods, our continuing efforts on the investigation of novel active compounds from marine
Verrucosispora
sp. MS100137 has led to the identification of a new polycyclic metabolite, abyssomicin Y (
1
), together with six known abyssomicin and proximicin analogs (
2
–
7
). Abyssomicin Y is a type I abyssomicin with an epoxide group at C-8 and C-9. Compounds
1
–
3
showed potent inhibitory effects against the influenza A virus; their observed inhibition rates were 97.9%, 98.3%, and 95.9%, respectively, at a concentration of 10 μM, and they displayed lower cytotoxicity than
4
. The structures were determined by different NMR techniques and HRMS experiments. This investigation revealed that OSMAC could serve as a useful method for enabling the activation of the silent genes in the microorganism and for the formation of previously unreported active secondary metabolites.</description><subject>Actinomycetes</subject><subject>Antiviral agents</subject><subject>Biological activity</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnological Products and Process Engineering</subject><subject>Biotechnology</subject><subject>Control</subject><subject>Cytotoxicity</subject><subject>Health aspects</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>Influenza viruses</subject><subject>Life Sciences</subject><subject>Liquid chromatography</subject><subject>Marine bacteria</subject><subject>Marine microorganisms</subject><subject>Mass spectrometry</subject><subject>Mass spectroscopy</subject><subject>Metabolites</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Microorganisms</subject><subject>Natural products</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Physiological aspects</subject><subject>Polyketides</subject><subject>Secondary metabolites</subject><subject>Testing</subject><subject>Toxicity</subject><subject>Transcription activation</subject><subject>Viruses</subject><issn>0175-7598</issn><issn>1432-0614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kl9rFDEUxYModl39Aj5IwBd9yJo_M5mZx6VULVQEq76GTHKzps4kazKzdf30pm6trIjkIZD8zuWew0HoKaMrRmnzKlPKa0Eo6wijnDWE30MLVglOqGTVfbSgrKlJU3ftCXqU8xWljLdSPkQngrVdJWS1QHmNA1xj3e9zjqM3PuBtHPZfYfIW8LWfvmAdJk98cMMM4YfGa7zzac5Ym8nv_LTHLsURazzq5AMQC8nvwOLPkNJsYvZ5G5PGebvC7y7L2kw0j9EDp4cMT27vJfr0-uzj6Vty8f7N-en6gpiaiYl0hjsmXS9tY6W1tnWWMzDOONo1tZBd3zAA7dri2NFKmBoYtNBD2xtjhRZL9OIwd5vitxnypEafDQyDDhDnrLgQnLYluLqgz_9Cr-KcQtmuUJXkspaFvqM2egBVIolT0uZmqFpLxmvGSvqFWv2DKsdCCTgGcL68HwleHgkKM8H3aaPnnNX55Ydjlh9Yk2LOCZzaJl-i3ytG1U0r1KEVqrRC_WpFMbBEz27dzf0I9k7yuwYFEAcgl6-wgfTH_n_G_gQ_CcCE</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Zhang, Jingyu</creator><creator>Li, Bixiao</creator><creator>Qin, Yujie</creator><creator>Karthik, Loganathan</creator><creator>Zhu, Guoliang</creator><creator>Hou, Chengjian</creator><creator>Jiang, Lan</creator><creator>Liu, Miaomiao</creator><creator>Ye, Xin</creator><creator>Liu, Mei</creator><creator>Hsiang, Tom</creator><creator>Dai, Huanqin</creator><creator>Zhang, Lixin</creator><creator>Liu, Xueting</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6581-6818</orcidid></search><sort><creationdate>20200201</creationdate><title>A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137</title><author>Zhang, Jingyu ; Li, Bixiao ; Qin, Yujie ; Karthik, Loganathan ; Zhu, Guoliang ; Hou, Chengjian ; Jiang, Lan ; Liu, Miaomiao ; Ye, Xin ; Liu, Mei ; Hsiang, Tom ; Dai, Huanqin ; Zhang, Lixin ; Liu, Xueting</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-9c2f16fb6d7d6ddd8fd21ecfcf0975369b71eeaf8432f043c5e1e8ebe8bccd3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Actinomycetes</topic><topic>Antiviral agents</topic><topic>Biological activity</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnological Products and Process Engineering</topic><topic>Biotechnology</topic><topic>Control</topic><topic>Cytotoxicity</topic><topic>Health aspects</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>Influenza viruses</topic><topic>Life Sciences</topic><topic>Liquid chromatography</topic><topic>Marine bacteria</topic><topic>Marine microorganisms</topic><topic>Mass spectrometry</topic><topic>Mass spectroscopy</topic><topic>Metabolites</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Microorganisms</topic><topic>Natural products</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Physiological aspects</topic><topic>Polyketides</topic><topic>Secondary metabolites</topic><topic>Testing</topic><topic>Toxicity</topic><topic>Transcription activation</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Jingyu</creatorcontrib><creatorcontrib>Li, Bixiao</creatorcontrib><creatorcontrib>Qin, Yujie</creatorcontrib><creatorcontrib>Karthik, Loganathan</creatorcontrib><creatorcontrib>Zhu, Guoliang</creatorcontrib><creatorcontrib>Hou, Chengjian</creatorcontrib><creatorcontrib>Jiang, Lan</creatorcontrib><creatorcontrib>Liu, Miaomiao</creatorcontrib><creatorcontrib>Ye, Xin</creatorcontrib><creatorcontrib>Liu, Mei</creatorcontrib><creatorcontrib>Hsiang, Tom</creatorcontrib><creatorcontrib>Dai, Huanqin</creatorcontrib><creatorcontrib>Zhang, Lixin</creatorcontrib><creatorcontrib>Liu, Xueting</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Global</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Applied microbiology and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Jingyu</au><au>Li, Bixiao</au><au>Qin, Yujie</au><au>Karthik, Loganathan</au><au>Zhu, Guoliang</au><au>Hou, Chengjian</au><au>Jiang, Lan</au><au>Liu, Miaomiao</au><au>Ye, Xin</au><au>Liu, Mei</au><au>Hsiang, Tom</au><au>Dai, Huanqin</au><au>Zhang, Lixin</au><au>Liu, Xueting</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137</atitle><jtitle>Applied microbiology and biotechnology</jtitle><stitle>Appl Microbiol Biotechnol</stitle><addtitle>Appl Microbiol Biotechnol</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>104</volume><issue>4</issue><spage>1533</spage><epage>1543</epage><pages>1533-1543</pages><issn>0175-7598</issn><eissn>1432-0614</eissn><abstract>Marine microorganisms live in dramatically different environments and have attracted much attention for their structurally unique natural products with potential strong biological activity. Based on the one strain-many compounds (OSMAC) strategy and liquid chromatography mass spectrometry (LC-MS) methods, our continuing efforts on the investigation of novel active compounds from marine
Verrucosispora
sp. MS100137 has led to the identification of a new polycyclic metabolite, abyssomicin Y (
1
), together with six known abyssomicin and proximicin analogs (
2
–
7
). Abyssomicin Y is a type I abyssomicin with an epoxide group at C-8 and C-9. Compounds
1
–
3
showed potent inhibitory effects against the influenza A virus; their observed inhibition rates were 97.9%, 98.3%, and 95.9%, respectively, at a concentration of 10 μM, and they displayed lower cytotoxicity than
4
. The structures were determined by different NMR techniques and HRMS experiments. This investigation revealed that OSMAC could serve as a useful method for enabling the activation of the silent genes in the microorganism and for the formation of previously unreported active secondary metabolites.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31894364</pmid><doi>10.1007/s00253-019-10217-2</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6581-6818</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0175-7598 |
ispartof | Applied microbiology and biotechnology, 2020-02, Vol.104 (4), p.1533-1543 |
issn | 0175-7598 1432-0614 |
language | eng |
recordid | cdi_proquest_miscellaneous_2332082175 |
source | SpringerLink Journals - AutoHoldings |
subjects | Actinomycetes Antiviral agents Biological activity Biomedical and Life Sciences Biotechnological Products and Process Engineering Biotechnology Control Cytotoxicity Health aspects Influenza Influenza A Influenza viruses Life Sciences Liquid chromatography Marine bacteria Marine microorganisms Mass spectrometry Mass spectroscopy Metabolites Microbial Genetics and Genomics Microbiology Microorganisms Natural products NMR Nuclear magnetic resonance Physiological aspects Polyketides Secondary metabolites Testing Toxicity Transcription activation Viruses |
title | A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A53%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20abyssomicin%20polyketide%20with%20anti-influenza%20A%20virus%20activity%20from%20a%20marine-derived%20Verrucosispora%20sp.%20MS100137&rft.jtitle=Applied%20microbiology%20and%20biotechnology&rft.au=Zhang,%20Jingyu&rft.date=2020-02-01&rft.volume=104&rft.issue=4&rft.spage=1533&rft.epage=1543&rft.pages=1533-1543&rft.issn=0175-7598&rft.eissn=1432-0614&rft_id=info:doi/10.1007/s00253-019-10217-2&rft_dat=%3Cgale_proqu%3EA612511143%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2346265623&rft_id=info:pmid/31894364&rft_galeid=A612511143&rfr_iscdi=true |